Preview

Современная ревматология

Расширенный поиск

Хондроитина сульфат: механизмы действия, эффективность и безопасность при терапии остеоартроза

https://doi.org/10.14412/1996-7012-2012-753

Полный текст:

Аннотация

Представления о патогенезе остеоартроза постоянно расширяются, появляются новые подходы к лечению этого заболевания. Хондроитина сульфат (ХС) имеет длительную историю применения, но до настоящего времени не все механизмы его действия полностью раскрыты. Результаты лабораторных и клинических исследований свидетельствуют о наличии у ХС симптоматических свойств, и главное, о возможном структурно-модифицирующем эффекте препарата. Это одно из наиболее интересных свойств ХС требует дальнейших крупномасштабных исследований. В настоящее время появились инъекционные формы ХС. В нашей стране выпускается препарат Артрадол®, содержащий ХС, его исследование планируется в нескольких ведущих ревматологических центрах России.

Литература

1. <div><p>Клинические рекомендации. Ревматология. Под ред. акад. РАМН Е.Л. Насонова. М.: ГЭОТАР-Медиа, 2010; 326.</p><p>Laurence R.C., Helmic C.G., Arnet P.C. et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in United States. Arthr Rheum 1998; 41: 778-99.</p><p>United States Senate Committee on Health, Education, Labor and Pensions, Sub committee on aging. Centre for Disease Control. Washington, D.C.: Department of Health and Human Services, 2004.</p><p>Фоломеева О.М., Амирджанова В.Н., Якушева Е.О. и др. Анализ структуры XIII класса болезней. Рос. ревматол. 1998; 1: 2-7.</p><p>Zhang W., Nuki G., Moskowitz R.W. et al. OARSI recommendations for the Management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil 2010; 18 (4): 476-99.</p><p>Conte A., Volpi N., Palmieri L. et al. Biochemical and pharmacological aspects of oral treatment with chondroitin sulfate. Arzneim Drug Res 1995; 45: 918-25.</p><p>Imada K., Oka H., Kawasaki D. et al. Anti-arthritic action mechanisms of natural chondroitin sulfate in human articular chondrocytes and synovial fibroblasts. Biol Pharm Bull 2010; 33(3): 410—4.</p><p>Volpi N. Quality of different chondroitin sulfate preparations in relation to their therapeutic activity. J Pharm Pharmacol 2009; 61(10): 1271-80.</p><p>Rainsford K.D. Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique. J Pharm Pharmacol 2009; 61(10): 1263—70.</p><p>Lauder R.M. Chondroitin sulfate: a complex molecule with potential impacts on a wide range of biological systems. Complement Ther Med 2009; 17(1): 56—62.</p><p>Volpi N. Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers. Osteoarthr Cartil 2003; 11(6): 433—41.</p><p>Volpi N. Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers. Osteoarthr Cartil 2002; 10(10): 768—77.</p><p>Ronca F., Palmieri L., Panicucci P. et al. Anti-inflammatory activity of chondroitin sulfate. Osteoarthr Cartil 1998; 6 (Suppl. A): 14-21.</p><p>Bassleer C., Rovati L., Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthr Cartil 1998; 6(6): 427—34.</p><p>Legendre F., Bauge C., Roche R. et al. Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1beta-stimulated chondrocytes-study in hypoxic alginate bead cultures. Osteoarthr Cartil 2008; 16(1): 105—14.</p><p>Wang L., Wang J., Almqvist K.F. et al. Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro. Clin Exp Rheum 2002; 20(5): 669-76.</p><p>Verbruggen G., Veys E.M. Influence of sulphated glycosaminoglycans upon proteoglycan metabolism of the synovial lining cells. Acta Rhum Belg 1977; 1(12): 75-92.</p><p>Martel-Pelletier J., Lajeunesse D., Pelletier J.P. Etiopathogenesis of osteoarthritis. In: Arthritis and Allied Conditions: A Textbook of Rheumatology. W.J. Koopman, L.W. Moreland (eds). Baltimore: lippincott, Wikings W., 2005: 2199—296.</p><p>Largo R., Roman-Blas J.A., Moreno-Rubio J. и др. Chondroitin sulfate improves synovitis in rabbits with chronic antigen-induced arthritis. Osteoarthr Cartil 2010; 18(Suppl. 1): S17-S23.</p><p>Pelletier J.P., Martel-Pelletier J., Abramson S.B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthr Rheum 2001; 44(6): 1237-47.</p><p>Chou M.M., Vergnolle N., McDougall J.J. et al. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med (Maywood) 2005; 230(4): 255-62.</p><p>Campo G.M., Avenoso A., Campo S. et al. Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chon drocytes. J Cell Biochem 2009; 106(1): 83—92.</p><p>Chan P.S., Caron J.P., Rosa G.J. et al. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthr Cartil 2005; 13(5): 387—94.</p><p>Cho S.Y., Sim J.S., Jeong C.S. et al. Effects of low molecular weight chondroitin sulfate on type II collagen-induced arthritis in DBA/1J mice. Biol Pharm Bull 2004; 27(1): 47—51.</p><p>Knäuper V., Lopez-Otin C., Smith B. et al. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271(3): 1544—50.</p><p>Holzmann J., Brandl N., Zemann A. et al. Assorted effects of TGFbeta and chondroitin sulfate on p38 and ERK1/2 activation levels in human articular chondrocytes stimulated with LPS. Osteoarthr Cartil 2006; 14: 519-25.</p><p>Monfort J., Nacher M., Montell E. et al. Chondroitin sulfate and Hyaluronic acid (500—730 kDa) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes. Drugs Exp Clin Res 2005; 31: 71-6.</p><p>Campo G.M., Avenoso A., Campo S. et al. Antioxidant activity of chondroitin sulfate. Adv Pharmacol 2006; 53: 417-31.</p><p>Campo G.M., Avenoso A., Campo S. et al. Chondroitin sulfate: antioxidant properties and beneficial effects. Mini Rev Med Chem 2006; 6(12): 1311—20.</p><p>Jomphe C., Gabriac M., Hale T.M. et al. Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappa B in interleukin-1beta-stimulated chondrocytes. Basic Clin Pharmacol Toxicol 2008; 102: 59-65.</p><p>Caraglia M., Beninati S.D., Alessandro A.M. et al. Alternative therapy of earth elements increases the chondroprotective effects of chondroitin sulfate in mice. Exp Mol Med 2005; 37: 476-81.</p><p>Vallicres M., du Souich P. Modulation of inflammation by chondroitin sulfate. Osteoarthr Cartil 2010; 18 (Suppl. 1): S1—S6.</p><p>Möller I., Perez M., Monfort J. et al. Effectiveness of chondroitin sulfate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study. Osteoarthr Cartil 2010; 18 (Suppl 1): S32-S40.</p><p>Kwan Tat S., Pelletier J.P., Lajeunesse D. et al. The differential expression of osteoprotegerin (OPG) and receptor of nuclear factor kB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cell. Clin Exp Rheum. In press.</p><p>Leeb B.F., Schweitzer H., Montag K. et al. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheum 2000; 27(1): 205—11.</p><p>McAlindon T.E., LaValley M.P., Gulin J.P. et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000; 283(11): 1469—75.</p><p>Bana G., Jamard B., Verrouil E. et al. Chondroitin sulfate in the management of hip and knee OA: an overview. Adv Pharmacol 2006; 53: 507-22.</p><p>Bruyere O., Burlet N., Delmas P.D. et al. Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. BMC Musculoskelet Dis 2008; 9: 165.</p><p>Clegg D.O., Reda D.J., Harris C.L. et al. Glucosamine, chondroitin sulfate and the two in combination for painful knee osteoarthritis. N Engl J Med 2006; 354(8): 795-808.</p><p>Hochberg M.C., Altman R.D., April K.T. et al. American college of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip and Knee. Arthr Car Res 2012; 64(4): 465-74.</p><p>Gabay C., Medinger-Sadowski C., Gascon D. et al. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, doubleblind, placebo-controlled clinical trial at a single center. Arthr Rheum 2011; 63(11): 3383—91.</p><p>Michel B.A., Stucki G., Frey D. et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthr Rheum 2005; 52(3): 779-86.</p><p>Kahan A., Uebelhart D., de Vathaire F. et al. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebocontrolled trial. Arthr Rheum 2009; 60(2): 524-33.</p><p>Hochberg M.C. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthr Cartil 2010; 18 (Suppl 1): S28-S31.</p><p>Lee Y.H., Woo J.H., Choi S.J. et al. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheum Int 2010; 30(3): 357—63.</p><p>Wildi L.M., Raynauld J.P., Martel-Pelletier J. et al. Chondroitin sulfate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis 2011; 70(6): 982-9.</p></div><br />


Для цитирования:


Аникин С.Г., Алексеева Л.И. Хондроитина сульфат: механизмы действия, эффективность и безопасность при терапии остеоартроза. Современная ревматология. 2012;6(3):78-82. https://doi.org/10.14412/1996-7012-2012-753

For citation:


Anikin S.G., Alekseeva L.I. Chondroitin sulfate: the mechanisms of action, its efficacy and safety in the therapy of osteoarthrosis. Modern Rheumatology Journal. 2012;6(3):78-82. (In Russ.) https://doi.org/10.14412/1996-7012-2012-753

Просмотров: 1048


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)